SEB Earnings Beat Forecasts on Higher Income
By Dominic Chopping
STOCKHOLM--Skandinaviska Enskilda Banken posted a better-than-expected first-quarter net profit, driven by a sharp rise in income.
The Sweden-based bank posted net profit of 9.5 billion kronor ($878.7 million), up from SEK9.39 billion a year earlier and ahead of the SEK8.84 billion forecast from analysts polled by FactSet.
Net interest income rose 4.1% to SEK11.77 billion, compared with an expected SEK12.12 billion.
"The strengthening macroeconomic picture in Sweden was partly reflected in an improved market sentiment," Chief Executive Johan Torgeby said.
"At the same time, the high interest rate environment continued to have a dampening effect on credit demand."
SEB has an overall ambition to grow earnings per share and reach the long-term aspirational target of 15% return on equity.
Its cost target for 2024 is below or equal to SEK29 billion, assuming average foreign-exchange rates during 2023.
The bank's common equity Tier 1 ratio--a key measure of financial strength--stood at 18.9% at the end of the quarter, down from 19.2% a year prior.
Write to Dominic Chopping at dominic.chopping@wsj.com
(END) Dow Jones Newswires
April 24, 2024 01:46 ET (05:46 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom